| Abnormal asymmetries in subcortical brain volume in schizophrenia N Okada, M Fukunaga, F Yamashita, D Koshiyama, H Yamamori, K Ohi, ... Molecular psychiatry 21 (10), 1460-1466, 2016 | 416 | 2016 |
| Higher plasma interleukin-6 (IL-6) level is associated with SSRI-or SNRI-refractory depression R Yoshimura, H Hori, A Ikenouchi-Sugita, W Umene-Nakano, N Ueda, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 33 (4), 722-726, 2009 | 252 | 2009 |
| Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients R Yoshimura, M Mitoma, A Sugita, H Hori, T Okamoto, W Umene, N Ueda, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (5), 1034-1037, 2007 | 249 | 2007 |
| Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses T Kishi, R Yoshimura, T Ikuta, N Iwata Frontiers in psychiatry 8, 308, 2018 | 217 | 2018 |
| A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder M Ikeda, A Takahashi, Y Kamatani, Y Okahisa, H Kunugi, N Mori, T Sasaki, ... Molecular psychiatry 23 (3), 639-647, 2018 | 198 | 2018 |
| High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors T Yukimasa, R Yoshimura, A Tamagawa, T Uozumi, K Shinkai, N Ueda, ... Pharmacopsychiatry 39 (02), 52-59, 2006 | 193 | 2006 |
| Time to recurrence after recovery from major depressive episodes and its predictors T Kanai, H Takeuchi, TA Furukawa, R Yoshimura, T Imaizumi, T Kitamura, ... Psychological Medicine 33 (5), 839-845, 2003 | 177 | 2003 |
| Stress at work alters serum brain-derived neurotrophic factor (BDNF) levels and plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels in healthy volunteers: BDNF and MHPG as … M Mitoma, R Yoshimura, A Sugita, W Umene, H Hori, H Nakano, N Ueda, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (3), 679-685, 2008 | 146 | 2008 |
| SIRT1 gene is associated with major depressive disorder in the Japanese population T Kishi, R Yoshimura, T Kitajima, T Okochi, T Okumura, T Tsunoka, ... Journal of affective disorders 126 (1-2), 167-173, 2010 | 142 | 2010 |
| Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia M Ikeda, Y Yamanouchi, Y Kinoshita, T Kitajima, R Yoshimura, ... Pharmacogenomics 9 (10), 1437-1443, 2008 | 138 | 2008 |
| Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed … T Okamoto, R Yoshimura, A Ikenouchi-Sugita, H Hori, W Umene-Nakano, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (5), 1185-1190, 2008 | 131 | 2008 |
| The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder T Kishi, R Yoshimura, Y Fukuo, T Okochi, S Matsunaga, ... European archives of psychiatry and clinical neuroscience 263, 105-118, 2013 | 126 | 2013 |
| Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6 S Kakihara, R Yoshimura, K Shinkai, C Matsumoto, M Goto, K Kaji, ... International clinical psychopharmacology 20 (2), 71-78, 2005 | 120 | 2005 |
| Reduction of brain γ-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study N Goto, R Yoshimura, J Moriya, S Kakeda, N Ueda, A Ikenouchi-Sugita, ... Schizophrenia research 112 (1-3), 192-193, 2009 | 109 | 2009 |
| Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression … M Ikeda, Y Tomita, A Mouri, M Koga, T Okochi, R Yoshimura, ... Biological psychiatry 67 (3), 263-269, 2010 | 102 | 2010 |
| Effects of olanzapine on plasma levels of catecholamine metabolites, cytokines, and brain-derived neurotrophic factor in schizophrenic patients H Hori, R Yoshimura, Y Yamada, A Ikenouchi, M Mitoma, Y Ida, ... International clinical psychopharmacology 22 (1), 21-27, 2007 | 97 | 2007 |
| The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in … R Yoshimura, T Kishi, A Suzuki, W Umene-Nakano, A Ikenouchi-Sugita, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (4), 1022-1025, 2011 | 88 | 2011 |
| Gray and white matter volumetric and diffusion tensor imaging (DTI) analyses in the early stage of first-episode schizophrenia J Moriya, S Kakeda, O Abe, N Goto, R Yoshimura, H Hori, N Ohnari, ... Schizophrenia research 116 (2-3), 196-203, 2010 | 86 | 2010 |
| Restless legs syndrome induced by lithium. T Terao, M Terao, R Yoshimura, K Abe Biological psychiatry, 1991 | 86 | 1991 |
| Relationship between interleukin (IL)-6 and brain morphology in drug-naïve, first-episode major depressive disorder using surface-based morphometry S Kakeda, K Watanabe, A Katsuki, K Sugimoto, N Igata, I Ueda, R Igata, ... Scientific Reports 8 (1), 10054, 2018 | 77 | 2018 |
